Enzo Biochem, Inc. - Product Pipeline Review - Q2 2011

Enzo Biochem, Inc. – Product Pipeline Review – Q2 2011

Summary

Global Market Direct’s pharmaceuticals report, “Enzo Biochem, Inc. - Product Pipeline Review - Q2 2011” provides data on the Enzo Biochem, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Enzo Biochem, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Enzo Biochem, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Enzo Biochem, Inc. - Brief Enzo Biochem, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Enzo Biochem, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Enzo Biochem, Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Enzo Biochem, Inc.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Enzo Biochem, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Enzo Biochem, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Enzo Biochem, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Enzo Biochem, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Enzo Biochem, Inc. and identify potential opportunities in those areas. SHOW LESS READ MORE >

List of Tables
List of Figures
Enzo Biochem, Inc. Snapshot
Enzo Biochem, Inc. Overview
Key Information
Key Facts
Enzo Biochem, Inc. – Research and Development Overview
Key Therapeutic Areas
Enzo Biochem, Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Enzo Biochem, Inc. – Pipeline Products Glance
Enzo Biochem, Inc. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Enzo Biochem, Inc. – Drug Profiles
EGS21
Product Description
Mechanism of Action
R&D Progress
EHT899
Product Description
Mechanism of Action
R&D Progress
Enzo Biochem, Inc. – Pipeline Analysis
Enzo Biochem, Inc. – Pipeline Products by Therapeutic Class
Enzo Biochem, Inc. - Pipeline Products By Target
Enzo Biochem, Inc. – Pipeline Products by Route of Administration
Enzo Biochem, Inc. – Pipeline Products by Molecule Type
Enzo Biochem, Inc. – Recent Pipeline Updates
Enzo Biochem, Inc. - Dormant Projects
Enzo Biochem, Inc. – Company Statement
Enzo Biochem, Inc. – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Financial Deals Landscape
Enzo Biochem, Inc., Deals Volume Summary, 2004 to YTD 2011
Enzo Biochem, Inc., Deals Summary By Region, 2004 to YTD 2011
Enzo Biochem, Inc., Deals Summary, 2004 to YTD 2011
Enzo Biochem, Inc. Detailed Deal Summary
Asset Purchase
Enzo Biochem Acquires Rights To A Drug Candidate
Acquisition
Enzo Biochem Acquires Assay Designs
Enzo Biochem Acquires BIOMOL International
Enzo Life Sciences Acquires 10 P’s
Enzo Life Sciences Acquires Axxora Life Sciences
Equity Offering
Enzo Biochem Completes Private Placement Of $15 Million
Enzo Biochem Completes Private Placement Of $46 Million
Enzo Biochem Enters Into An Agreement With GeneNews
Enzo Life Sciences Enters Into Co-Marketing Agreement With BioTek Instruments
Enzo Biochem Enters Into Co-Development Agreement With National Institutes of Health
Licensing Agreements
Enzo Life Sciences Enters Into Agreement With Abbott Laboratories
Enzo Biochem Enters Into Licensing Agreement With LBS Technologies
Enzo Life Sciences Enters Into License Agreement With Digene
Enzo Life Sciences Enters Into Licensing Agreement With GlaxoSmithKline
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Enzo Biochem, Inc. – Pipeline by Therapy Area and Indication, 2011
Enzo Biochem, Inc. – Pipeline by Stage of Development, 2011
Enzo Biochem, Inc. – Monotherapy Products in Pipeline, 2011
Enzo Biochem, Inc. - Phase II, 2011
Enzo Biochem, Inc. - Pipeline By Therapeutic Class, 2011
Enzo Biochem, Inc. - Pipeline By Target, 2011
Enzo Biochem, Inc. – Pipeline By Route of Administration, 2011
Enzo Biochem, Inc. – Pipeline By Molecule Type, 2011
Enzo Biochem, Inc. – Recent Pipeline Updates, 2011
Enzo Biochem, Inc. - Dormant Developmental Projects, 2010
Enzo Biochem, Inc., Other Locations
Enzo Biochem, Inc., Subsidiaries
Enzo Biochem, Inc., Deals Summary, 2004 to YTD 2011
Enzo Biochem, Inc., Deals Summary by Region, 2004 to YTD 2011
Enzo Biochem, Inc., Deals Summary, 2004 to YTD 2011

List of Figures
Enzo Biochem, Inc. – Pipeline by Therapy Area and Indication, 2011
Enzo Biochem, Inc. – Pipeline by Stage of Development, 2011
Enzo Biochem, Inc. – Monotherapy Products in Pipeline, 2011
Enzo Biochem, Inc. – Pipeline By Therapeutic Class, 2011
Enzo Biochem, Inc. - Pipeline By Target, 2011
Enzo Biochem, Inc. – Pipeline By Molecule Type, 2011